会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD FOR TREATING INFLUENZA A VIRUS INFECTION
    • 用于治疗流感病毒感染的方法
    • WO2016109541A1
    • 2016-07-07
    • PCT/US2015/067870
    • 2015-12-29
    • ACADEMIA SINICALIANG, Chi-Ming
    • HSIEH, Shie-LiangCHANG, Yung-ChiHUANG, Ming-Ting
    • A61K38/00
    • A61K38/177C07K14/70578C07K2319/30
    • Disclosed herein is a method of treating influenza A virus (IAV) infection by a fusion protein. According to some embodiments of the present disclosure, the fusion protein comprises a HBD peptide and a IgG1 Fc region. According to other embodiments of the present disclosure, the fusion protein comprises a DcR3 protein and a IgG1 Fc region. The present fusion protein is found to possess inhibitory effects on IAV-induced secretion of the inflammatory cytokine, and IAV-induced infiltration of inflammatory cell into the lung tissue. Accordingly, the fusion protein is useful for developing a medicament for the treatment or prophylaxis of IAV infection and/or ameliorating pulmonary injury caused by excessive inflammation associated with IAV infection in a subject.
    • 本文公开了一种通过融合蛋白治疗甲型流感病毒(IAV)感染的方法。 根据本公开的一些实施方案,融合蛋白包含HBD肽和IgG1 Fc区。 根据本公开的其它实施方案,融合蛋白包含DcR3蛋白和IgG1 Fc区。 发现本发现的融合蛋白具有对IAV诱导的炎症细胞因子分泌的抑制作用,并且IAV诱导的炎性细胞浸润到肺组织中。 因此,融合蛋白可用于开发用于治疗或预防IAV感染和/或改善由受试者中与IAV感染相关的过度炎症引起的肺损伤的药物。